|Articles|September 1, 2004

Hope on the horizon for treating choroidal neovascularization

Photodynamic therapy with verteporfin is the most promising of the FDA-approved therapies for exudative CNV.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME